These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8646527)

  • 21. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2.
    Medcalf RL; Stasinopoulos SJ
    FEBS J; 2005 Oct; 272(19):4858-67. PubMed ID: 16176260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001.
    Huber K; Christ G; Wojta J; Gulba D
    Thromb Res; 2001 Sep; 103 Suppl 1():S7-19. PubMed ID: 11567664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q; Shaltiel S
    BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serine proteinase inhibitors in arthropod immunity.
    Kanost MR
    Dev Comp Immunol; 1999; 23(4-5):291-301. PubMed ID: 10426423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutral proteinases and their inhibitors in the loosening of total hip prostheses.
    Takagi M
    Acta Orthop Scand Suppl; 1996 Oct; 271():3-29. PubMed ID: 8975533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of the serpin superfamily.
    Law RH; Zhang Q; McGowan S; Buckle AM; Silverman GA; Wong W; Rosado CJ; Langendorf CG; Pike RN; Bird PI; Whisstock JC
    Genome Biol; 2006; 7(5):216. PubMed ID: 16737556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.
    Nar H; Bauer M; Stassen JM; Lang D; Gils A; Declerck PJ
    J Mol Biol; 2000 Mar; 297(3):683-95. PubMed ID: 10731421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serpins are getting hotter.
    Salvesen GS; Scott FL
    Structure; 2003 Apr; 11(4):364-5. PubMed ID: 12679013
    [No Abstract]   [Full Text] [Related]  

  • 29. Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies.
    Duffy MJ
    Clin Chem; 2002 Aug; 48(8):1194-7. PubMed ID: 12142372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrophobic accessible surface areas are proportional to binding energies of serine protease-protein inhibitor complexes.
    Goto K
    Biochem Biophys Res Commun; 1995 Jan; 206(2):497-501. PubMed ID: 7826367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the type of surgical operation influence the changes observed in fibrinolytic activity after cardiopulmonary bypass?
    Sánchez JM; Martin JM
    Chest; 1997 Sep; 112(3):856-7. PubMed ID: 9315832
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
    Dewerchin M; Collen D; Lijnen HR
    Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
    Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystallization and preliminary x-ray analysis of complexes of porcine pancreatic elastase with two natural inhibitors.
    Hilpert K; Wessner H; Scholz C; Scheerer P; Volkmer-Engert R; Kraubeta N
    Protein Pept Lett; 2004 Aug; 11(4):393-9. PubMed ID: 15327373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallization and preliminary X-ray studies of two serine proteinase inhibitors, BGIA and BGIT, from the seeds of bitter gourd.
    Kondo H; Nakanose J; Nakagawa A; Tanaka I; Kimura M; Funatsu G
    J Struct Biol; 1997 Nov; 120(2):204-6. PubMed ID: 9417986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serpins: finely balanced conformational traps.
    Pike RN; Bottomley SP; Irving JA; Bird PI; Whisstock JC
    IUBMB Life; 2002 Jul; 54(1):1-7. PubMed ID: 12387568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of positively charged residues contributing to the stability of plasminogen activator inhibitor 1.
    Gils A; Lu J; Aertgeerts K; Knockaert I; Declerck PJ
    FEBS Lett; 1997 Sep; 415(2):192-5. PubMed ID: 9350994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A novel function of anti-fibrinolytic factor, PAI-1, in the central nervous system: a possible role as the neurotrophic factor].
    Imatoh T; Soeda S; Ochiai T; Shimeno H
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):64P-66P. PubMed ID: 12491782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI.
    Lauber T; Schulz A; Schweimer K; Adermann K; Marx UC
    J Mol Biol; 2003 Apr; 328(1):205-19. PubMed ID: 12684009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of plasminogen activator inhibitor 1 gene expression in adipocytes by thiazolidinediones.
    Ihara H; Urano T; Takada A; Loskutoff DJ
    FASEB J; 2001 May; 15(7):1233-5. PubMed ID: 11344098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.